BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 30238327)

  • 1. Surgical outcomes and predictors of glucose metabolism alterations for growth hormone-secreting pituitary adenomas: a hospital-based study of 151 cases.
    He W; Yan L; Wang M; Li Q; He M; Ma Z; Ye Z; Zhang Q; Zhang Y; Qiao N; Lu Y; Ye H; Lu B; Shou X; Zhao Y; Li Y; Li S; Zhang Z; Shen M; Wang Y
    Endocrine; 2019 Jan; 63(1):27-35. PubMed ID: 30238327
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low insulin resistance after surgery predicts poor GH suppression one year after complete resection for acromegaly: a retrospective study.
    Edo N; Morita K; Suzuki H; Takeshita A; Miyakawa M; Fukuhara N; Nishioka H; Yamada S; Takeuchi Y
    Endocr J; 2016 May; 63(5):469-77. PubMed ID: 26949262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation analysis between short-term insulin-like growth factor-I and glucose intolerance status after transsphenoidal adenomectomy in acromegalic patients: a large retrospective study from a single center in China.
    Li YL; Zhang S; Guo XP; Gao L; Lian W; Yao Y; Deng K; Wang RZ; Xing B
    Arch Endocrinol Metab; 2019; 63(2):157-166. PubMed ID: 30916168
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body mass index and insulin-like growth factor 1 as risk factors for discordant growth hormone and insulin-like growth factor 1 levels following pituitary surgery in acromegaly.
    Zhang S; Li Y; Guo X; Gao L; Lian W; Yao Y; Feng M; Bao X; Wang R; Xing B
    J Formos Med Assoc; 2018 Jan; 117(1):34-41. PubMed ID: 28341329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly surgery in Manchester revisited--the impact of reducing surgeon numbers and the 2010 consensus guidelines for disease remission.
    Wang YY; Higham C; Kearney T; Davis JR; Trainer P; Gnanalingham KK
    Clin Endocrinol (Oxf); 2012 Mar; 76(3):399-406. PubMed ID: 21824170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improvement of insulin resistance following transsphenoidal surgery in patients with acromegaly: correlation with serum IGF-I levels.
    Mori K; Iwasaki Y; Kawasaki-Ogita Y; Honjo S; Hamamoto Y; Tatsuoka H; Fujimoto K; Ikeda H; Wada Y; Takahashi Y; Takahashi J; Koshiyama H
    J Endocrinol Invest; 2013 Nov; 36(10):853-9. PubMed ID: 23665535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pure endoscopic transsphenoidal surgery for treatment of acromegaly: results of 67 cases treated in a pituitary center.
    Gondim JA; Almeida JP; de Albuquerque LA; Gomes E; Schops M; Ferraz T
    Neurosurg Focus; 2010 Oct; 29(4):E7. PubMed ID: 20887132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Percent reduction of growth hormone levels correlates closely with percent resected tumor volume in acromegaly.
    Schwyzer L; Starke RM; Jane JA; Oldfield EH
    J Neurosurg; 2015 Apr; 122(4):798-802. PubMed ID: 25423276
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Postoperative GH and Degree of Reduction in IGF-1 Predicts Postoperative Hormonal Remission in Acromegaly.
    Cardinal T; Collet C; Wedemeyer M; Singer PA; Weiss M; Zada G; Carmichael JD
    Front Endocrinol (Lausanne); 2021; 12():743052. PubMed ID: 34867787
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Revisiting the Role of Insulin-like Growth Factor-1 Measurement After Surgical Treatment of Acromegaly.
    Jung IH; Choi S; Ku CR; Lee SG; Lee EJ; Kim SH; Kim EH
    J Clin Endocrinol Metab; 2021 Jun; 106(7):e2589-e2599. PubMed ID: 33738470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The impact of transsphenoidal surgery on glucose homeostasis and insulin resistance in acromegaly.
    Stelmachowska-Banaś M; Zieliński G; Zdunowski P; Podgórski J; Zgliczyński W
    Neurol Neurochir Pol; 2011; 45(4):328-34. PubMed ID: 22101993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Preoperative growth hormone response to thyrotropin-releasing hormone and oral glucose tolerance test in acromegaly: a retrospective evaluation of 50 patients.
    De Marinis L; Mancini A; Bianchi A; Gentilella R; Valle D; Giampietro A; Zuppi P; Anile C; Maira G; Giustina A
    Metabolism; 2002 May; 51(5):616-21. PubMed ID: 11979395
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preoperative Fasting C-Peptide Acts as a Promising Predictor of Improved Glucose Tolerance in Patients With Acromegaly After Transsphenoidal Surgery: A Retrospective Study of 64 Cases From a Large Pituitary Center in China.
    Wang Z; Gao L; Guo X; Feng C; Deng K; Lian W; Feng M; Bao X; Xing B
    Front Endocrinol (Lausanne); 2019; 10():736. PubMed ID: 31736874
    [No Abstract]   [Full Text] [Related]  

  • 14. Changing patterns of insulin-like growth factor-I and glucose-suppressed growth hormone levels after pituitary surgery in patients with acromegaly.
    Espinosa-de-los-Monteros AL; Mercado M; Sosa E; Lizama O; Guinto G; Lopez-Felix B; Garcia O; Hernández I; Ovalle A; Mendoza V
    J Neurosurg; 2002 Aug; 97(2):287-92. PubMed ID: 12186455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical, hormonal and magnetic resonance imaging (MRI) predictors of transsphenoidal surgery outcome in acromegaly.
    Bourdelot A; Coste J; Hazebroucq V; Gaillard S; Cazabat L; Bertagna X; Bertherat J
    Eur J Endocrinol; 2004 Jun; 150(6):763-71. PubMed ID: 15191345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low serum IGF-I/GH ratio is associated with abnormal glucose tolerance in acromegaly.
    Fukuoka H; Takahashi Y; Iida K; Kudo T; Nishizawa H; Imanaka M; Takeno R; Iguchi G; Takahashi K; Okimura Y; Kaji H; Chihara K
    Horm Res; 2008; 69(3):165-71. PubMed ID: 18219220
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fluctuation analysis of postoperative secretory status in patients operated for acromegaly.
    Graillon T; Castinetti F; Boucekine M; Cuny T; Morange I; Fuentes S; Figarella-Branger D; Albarel F; Brue T; Dufour H
    Ann Endocrinol (Paris); 2020 Feb; 81(1):11-17. PubMed ID: 31982107
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impaired beta-cell function in the presence of reduced insulin sensitivity determines glucose tolerance status in acromegalic patients.
    Kasayama S; Otsuki M; Takagi M; Saito H; Sumitani S; Kouhara H; Koga M; Saitoh Y; Ohnishi T; Arita N
    Clin Endocrinol (Oxf); 2000 May; 52(5):549-55. PubMed ID: 10792333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolic glucose status and pituitary pathology portend therapeutic outcomes in acromegaly.
    Cheng S; Al-Agha R; Araujo PB; Serri O; L Asa S; Ezzat S
    PLoS One; 2013; 8(9):e73543. PubMed ID: 24039977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Lowered ghrelin levels in acromegaly—normalization after treatment].
    Kozakowski J; Rabijewski M; Zgliczyński W
    Endokrynol Pol; 2005; 56(6):862-70. PubMed ID: 16821203
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.